ERBB2 and neoplasm: Despite this, sCNAphase was able to detect at least 12 copies of the pathologically relevant ERBB2 in HCC1954 and HCC2218 across the entire cohort of mixtures (Supplementary Data), highlighting the diagnostic potential of sCNAphase (38,39) at even 5% tumor DNA.